Internet-based indicated prevention of anxiety and depression disorder onset three-arm randomized clinical trial - Top-Institutions - MDSpire

Internet-based indicated prevention of anxiety and depression disorder onset three-arm randomized clinical trial

  • By

  • Anna-Carlotta Zarski

  • Kiona K. Weisel

  • Thomas Berger

  • Tobias Krieger

  • Michael P. Schaub

  • Matthias Berking

  • Dennis Görlich

  • Corinna Jacobi

  • Rosa Baños

  • Cristina Botella

  • Rocio Herrero

  • David D. Ebert

  • October 1, 2025

  • 0 min

Share

Top Institutions in General Medicine

Brief introduction explaining scope and methodology.

  • #1

    University of Oxford
    University of Oxford

    Oxford, Oxfordshire

    Key Differentiators

    • Psychiatry
    • Digital Mental Health
    • Clinical Psychology

  • #2

    University of California, Los Angeles (UCLA)
    University of California, Los Angeles (UCLA)

    Los Angeles, California

    Key Differentiators

    • Psychiatry
    • Digital Health
    • Preventive Medicine

  • #3

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, Stockholm County

    Key Differentiators

    • Psychiatry
    • Clinical Psychology
    • Digital Mental Health

  • #4

    University of Melbourne
    University of Melbourne

    Melbourne, Victoria

    Key Differentiators

    • Psychiatry
    • Digital Mental Health
    • Preventive Psychiatry

  • #5

    Harvard Medical School
    Harvard Medical School

    Boston, Massachusetts

    Key Differentiators

    • Psychiatry
    • Behavioral Health
    • Digital Health

Original Source(s)

Internet-based indicated prevention of anxiety and depression disorder onset three-arm randomized clinical trial

  • by Anna-Carlotta Zarski, Kiona K. Weisel, Thomas Berger, Tobias Krieger, Michael P. Schaub, Matthias Berking, Dennis Görlich, Corinna Jacobi, Rosa Baños, Cristina Botella, Rocio Herrero, David D. Ebert

  • October 1, 2025

Related Content

Investigating the Impact of Interoceptive Awareness on Anxiety Traits and Symptoms

Personalised modelling of routine variability and affective states

Explainable AI-driven precision clinical trial enrichment: demonstration of the NetraAI platform with a phase II depression trial